Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

NCT00718172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

81

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

PROCEDURE: Liver Biopsy
DRUG: Peginterferon & Ribavirin for Hepatitis C
DRUG: Pre-treatment Ribavirin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)